Health Canada
- Status: approved
🇨🇦 Intraperitoneal Lignocaine in Canada
Intraperitoneal Lignocaine (Intraperitoneal Lignocaine) regulatory status in Canada.
Marketing authorisation
Intraperitoneal Lignocaine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Intraperitoneal Lignocaine approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Intraperitoneal Lignocaine in Canada?
Jawaharlal Institute of Postgraduate Medical Education & Research is the originator. The local marketing authorisation holder may differ — check the official source linked above.